0.375 ML Eligard 120 MG/ML Prefilled Syringe

RxCUI
825325
RxNorm name
0.375 ML Eligard 120 MG/ML Prefilled Syringe
Display name
0.375 ML Eligard 120 MG/ML Prefilled Syringe
Full name
0.375 ML Eligard 120 MG/ML Prefilled Syringe
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:17

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
EligardLEUPROLIDE ACETATETOLMAR Inc.b7b679a9-6823-4ef8-8d31-3ab5058ffcfc2026-04-30Warnings, Adverse reactionsExact identifier
rxcui: 825325
ELIGARDLEUPROLIDE ACETATETOLMAR Inc.b78d1919-9dee-44fa-90f9-e0a26d32481d2019-04-29Warnings, Adverse reactionsExact identifier
rxcui: 825325

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
b78d1919-9dee-44fa-90f9-e0a26d32481d0.375 ML Eligard 120 MG/ML Prefilled SyringeSY51These highlights do not include all the information needed to use ELIGARD ® safely and effectively. See full prescribing information for ELIGARD ® . ELIGARD ® (leuprolide acetate) for injectable suspension, for subcutaneous use Initial U.S. Approval: 200220190429
b78d1919-9dee-44fa-90f9-e0a26d32481d0.375 ML leuprolide acetate 120 MG/ML Prefilled Syringe [Eligard]SBD51These highlights do not include all the information needed to use ELIGARD ® safely and effectively. See full prescribing information for ELIGARD ® . ELIGARD ® (leuprolide acetate) for injectable suspension, for subcutaneous use Initial U.S. Approval: 200220190429
b78d1919-9dee-44fa-90f9-e0a26d32481dEligard Every 6 Months 45 MG per 0.375 ML Prefilled SyringeSY51These highlights do not include all the information needed to use ELIGARD ® safely and effectively. See full prescribing information for ELIGARD ® . ELIGARD ® (leuprolide acetate) for injectable suspension, for subcutaneous use Initial U.S. Approval: 200220190429
b78d1919-9dee-44fa-90f9-e0a26d32481dEligard 45 MG per 0.375 ML Prefilled SyringeSY51These highlights do not include all the information needed to use ELIGARD ® safely and effectively. See full prescribing information for ELIGARD ® . ELIGARD ® (leuprolide acetate) for injectable suspension, for subcutaneous use Initial U.S. Approval: 200220190429
b78d1919-9dee-44fa-90f9-e0a26d32481dEligard 45 MG in 0.375 ML (6 month) Prefilled SyringePSN51These highlights do not include all the information needed to use ELIGARD ® safely and effectively. See full prescribing information for ELIGARD ® . ELIGARD ® (leuprolide acetate) for injectable suspension, for subcutaneous use Initial U.S. Approval: 200220190429
b7b679a9-6823-4ef8-8d31-3ab5058ffcfcEligard 45 MG in 0.375 ML (6 month) Prefilled SyringePSN19These highlights do not include all the information needed to use ELIGARD ® safely and effectively. See full prescribing information for ELIGARD. ELIGARD (leuprolide acetate) for injectable suspension, for subcutaneous use Initial U.S. Approval: 200220260430
b7b679a9-6823-4ef8-8d31-3ab5058ffcfc0.375 ML Eligard 120 MG/ML Prefilled SyringeSY19These highlights do not include all the information needed to use ELIGARD ® safely and effectively. See full prescribing information for ELIGARD. ELIGARD (leuprolide acetate) for injectable suspension, for subcutaneous use Initial U.S. Approval: 200220260430
b7b679a9-6823-4ef8-8d31-3ab5058ffcfcEligard 45 MG per 0.375 ML Prefilled SyringeSY19These highlights do not include all the information needed to use ELIGARD ® safely and effectively. See full prescribing information for ELIGARD. ELIGARD (leuprolide acetate) for injectable suspension, for subcutaneous use Initial U.S. Approval: 200220260430
b7b679a9-6823-4ef8-8d31-3ab5058ffcfcEligard Every 6 Months 45 MG per 0.375 ML Prefilled SyringeSY19These highlights do not include all the information needed to use ELIGARD ® safely and effectively. See full prescribing information for ELIGARD. ELIGARD (leuprolide acetate) for injectable suspension, for subcutaneous use Initial U.S. Approval: 200220260430
b7b679a9-6823-4ef8-8d31-3ab5058ffcfc0.375 ML leuprolide acetate 120 MG/ML Prefilled Syringe [Eligard]SBD19These highlights do not include all the information needed to use ELIGARD ® safely and effectively. See full prescribing information for ELIGARD. ELIGARD (leuprolide acetate) for injectable suspension, for subcutaneous use Initial U.S. Approval: 200220260430